Larry E. Millikan

3.1k total citations
127 papers, 2.1k citations indexed

About

Larry E. Millikan is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Larry E. Millikan has authored 127 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Dermatology, 32 papers in Epidemiology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Larry E. Millikan's work include Nail Diseases and Treatments (16 papers), Autoimmune Bullous Skin Diseases (15 papers) and Medicine and Dermatology Studies History (12 papers). Larry E. Millikan is often cited by papers focused on Nail Diseases and Treatments (16 papers), Autoimmune Bullous Skin Diseases (15 papers) and Medicine and Dermatology Studies History (12 papers). Larry E. Millikan collaborates with scholars based in United States, United Kingdom and Egypt. Larry E. Millikan's co-authors include Kenneth L. Tyler, R R Hook, G Russo, Patrick Manning, Carolyn Watson, Sharon R. Smith, David R. Bickers, Erin Boh, Mark A. Chastain and Lawrence Charles Parish and has published in prestigious journals such as JAMA, JNCI Journal of the National Cancer Institute and International Journal of Cancer.

In The Last Decade

Larry E. Millikan

120 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry E. Millikan United States 27 790 562 289 253 228 127 2.1k
James E. Rasmussen United States 25 581 0.7× 351 0.6× 168 0.6× 119 0.5× 138 0.6× 86 1.5k
Ida Orengo United States 22 818 1.0× 718 1.3× 112 0.4× 142 0.6× 275 1.2× 109 2.2k
W.E. Parish United Kingdom 28 498 0.6× 178 0.3× 132 0.5× 464 1.8× 269 1.2× 85 2.4k
Roman Nowicki Poland 22 955 1.2× 538 1.0× 325 1.1× 286 1.1× 254 1.1× 229 2.4k
Jorge Ocampo‐Candiani Mexico 28 1.2k 1.5× 920 1.6× 480 1.7× 162 0.6× 318 1.4× 239 3.0k
Yang Won Lee South Korea 25 893 1.1× 541 1.0× 208 0.7× 172 0.7× 153 0.7× 110 1.6k
Stephen C. Pflugfelder United States 26 485 0.6× 253 0.5× 150 0.5× 345 1.4× 235 1.0× 46 3.9k
J. D. Bos Netherlands 26 1.4k 1.8× 289 0.5× 780 2.7× 516 2.0× 258 1.1× 49 3.1k
Eric D. Donnenfeld United States 46 424 0.5× 832 1.5× 47 0.2× 111 0.4× 187 0.8× 219 6.1k
Vikram K. Mahajan India 21 471 0.6× 522 0.9× 300 1.0× 36 0.1× 135 0.6× 122 1.7k

Countries citing papers authored by Larry E. Millikan

Since Specialization
Citations

This map shows the geographic impact of Larry E. Millikan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Millikan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Millikan more than expected).

Fields of papers citing papers by Larry E. Millikan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry E. Millikan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Millikan. The network helps show where Larry E. Millikan may publish in the future.

Co-authorship network of co-authors of Larry E. Millikan

This figure shows the co-authorship network connecting the top 25 collaborators of Larry E. Millikan. A scholar is included among the top collaborators of Larry E. Millikan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry E. Millikan. Larry E. Millikan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Millikan, Larry E.. (2010). Current concepts in systemic and topical therapy for superficial mycoses. Clinics in Dermatology. 28(2). 212–216. 16 indexed citations
2.
Millikan, Larry E.. (2000). Unapproved treatments or indications in dermatology: physical therapy including balneotherapy. Clinics in Dermatology. 18(1). 125–129. 3 indexed citations
3.
Millikan, Larry E.. (2000). Pruritus: unapproved treatments or indications. Clinics in Dermatology. 18(2). 149–152. 5 indexed citations
4.
Chastain, Mark A. & Larry E. Millikan. (2000). Pilomatrix dysplasia in an immunosuppressed patient. Journal of the American Academy of Dermatology. 43(1). 118–122. 30 indexed citations
5.
Millikan, Larry E.. (2000). Adapalene: an update on newer comparative studies between the various retinoids. International Journal of Dermatology. 39(10). 784–788. 38 indexed citations
6.
Millikan, Larry E.. (1999). Recognizing rosacea. Postgraduate Medicine. 105(2). 149–158. 16 indexed citations
7.
Millikan, Larry E.. (1999). History and epidemiology of alcohol use and abuse. Clinics in Dermatology. 17(4). 353–356. 1 indexed citations
8.
Chastain, Mark A., et al.. (1999). Propylthiouracil hypersensitivity: Report of two patients with vasculitis and review of the literature. Journal of the American Academy of Dermatology. 41(5). 757–764. 32 indexed citations
9.
Millikan, Larry E.. (1999). Alcoholism among health professionals: prevalence and special problems. Clinics in Dermatology. 17(4). 361–363. 3 indexed citations
10.
Millikan, Larry E., et al.. (1999). A new therapeutic approach to type II leprosy reaction. International Journal of Dermatology. 38(12). 931–933. 15 indexed citations
11.
Millikan, Larry E.. (1999). Anecdotal Therapies. Advances in experimental medicine and biology. 455. 407–411. 1 indexed citations
12.
Russo, G, et al.. (1995). GENETIC AND ACQUIRED CUTANEOUS DISORDERS ASSOCIATED WITH INTERNAL MALIGNANCY. International Journal of Dermatology. 34(11). 749–758. 6 indexed citations
13.
Krotoski, Wojciech A., et al.. (1993). LEPROMIN RESPONSES IN RECIPIENTS OE A CANDIDATE ANTILEPROSY BACTERIN VACCINE (WHO‐IMMLEP MYCOBACTERIUM LEPRAE KILLED PREPARATION) IN THE USA. International Journal of Dermatology. 32(3). 191–193. 2 indexed citations
14.
Millikan, Larry E.. (1991). Fibrel and wound healing. Clinics in Dermatology. 9(4). 569–572. 3 indexed citations
15.
DODD, W. ALAN, Bernard S. Goffe, R. W. Goltz, et al.. (1990). A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. Cutis. 46(1). 84–88. 6 indexed citations
16.
Smith, Edgar B., Karen Wiss, Jon M. Hanifin, et al.. (1990). Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis. Journal of the American Academy of Dermatology. 22(6). 1116–1117. 19 indexed citations
17.
Lowe, Nicholas J., et al.. (1989). Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial.. PubMed. 43(3). 283–6. 19 indexed citations
18.
Parish, Lawrence Charles, Larry E. Millikan, & Joseph A. Witkowski. (1989). The Modern Story of Anthralin. International Journal of Dermatology. 28(6). 373–374. 4 indexed citations
19.
Witkowski, Joseph A., et al.. (1988). Cutaneous Torsion Stress Alias the Decubitus Ulcer: A Felony. International Journal of Dermatology. 27(6). 375–375. 4 indexed citations
20.
Millikan, Larry E.. (1987). Wound healing and dermatologic dressings. Clinics in Dermatology. 5(4). 31–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026